Login to Your Account



Array picks Ono as partner in Japan, South Korea

By Marie Powers
News Editor

Wednesday, May 31, 2017

With positive news flow on clinical development, Array Biopharma Inc. stayed busy on the partnering front, selecting Ono Pharmaceutical Co. Ltd. to license, develop and commercialize its late-stage oncology compounds, binimetinib and encorafenib, in Japan and South Korea.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription